Brigham & Women’s Hospital, Harvard Medical School
United States
Vortrag
Cardiovascular effectiveness of Empagliflozin compared to DPP4 inhibitors and to GLP1 receptor agonists: interim analysis from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study
Speaker